Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,735 across all filing types
Latest filing 2023-08-04 Director's Dealing
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
112年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, independent directors, and senior management. It lists their current holdings, pledged shares, and related percentages. The content focuses on insider share transactions and holdings rather than financial results, management changes, or meeting materials. The document length is 3197 characters, which is relatively short and focused on insider shareholding data. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. There is no indication of other report types such as annual reports, earnings releases, or regulatory filings. Therefore, the document is best classified as a Director's Dealing report.
2023-08-04 Chinese
112年07月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, senior management, and their related parties. It includes data on shares held at appointment, changes during the month, and current holdings, with specific mention of identities such as chairman, general manager, directors, independent directors, and financial department heads. This type of detailed insider shareholding disclosure aligns with the category of Director's Dealing, which reports personal share transactions by company directors and executives. There is no indication of it being a full financial report, earnings release, or other types of filings. The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-08-04 Chinese
112年7月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, capital increases, capital reductions, and dates of regulatory approvals. It is a structured disclosure of capital changes rather than a narrative report or announcement. The document length is short (861 characters), but it is not merely an announcement of a report publication or a certification. It specifically details capital changes and capital structure information, which aligns with the category for announcements regarding new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2023-07-19 Chinese
112年5月變更登記
Share Issue/Capital Change Classification · 95% confidence The document is a brief disclosure of the company's capital structure, including authorized capital, paid-in capital, capital increases, and decreases. It contains no financial statements, no management discussion, no earnings data, and no detailed report content. The document length is only 861 characters, which is very short and resembles a regulatory announcement or a capital structure update. It does not qualify as a full financial report or detailed filing. The content fits best with a Share Issue/Capital Change announcement, as it details changes in capital stock and related approvals.
2023-07-19 Chinese
112年年報及股東會資料 — 2023_4737_20230630F05.pdf
AGM Information Classification · 95% confidence The document is a detailed record of the Annual General Meeting (AGM) of 華廣生技股份有限公司 held on June 30, 2023 (Republic of China year 112). It includes attendance details, chairman's speech, reports on the previous fiscal year's business report, audit committee review report, employee and director remuneration, profit distribution, amendments to ethical conduct guidelines, approval of financial statements, dividend distribution, amendments to company articles, election of independent directors, and Q&A session. The document also contains attachments such as the business report, audit committee report, ethical conduct amendments, auditor's reports, profit distribution table, and company articles amendments. The content is comprehensive and covers the full proceedings and materials of the AGM, including financial results and corporate governance matters. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. Although it contains financial data, the primary nature is the AGM minutes and related reports presented at the meeting, not a standalone annual report or audit report. Therefore, the correct classification is AGM-R with high confidence.
2023-07-13 Chinese
112年年報及股東會資料 — 2022_4737_20230630FE4.pdf
Regulatory Filings
2023-07-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.